& Johnson is preparing to test out a new kind of HIV vaccine that
will target many strains of HIV, which will happen later this year in
both Europe and the United States.
goal, J&J said, is to eradicate a disease that has killed over 35
million people since it was first reported in 1981.
innovative study will include about 3,800 gay and bisexual men.
According to U.S. National Institute of Allergy and Infectious
Diseases Director Anthony Fauci, the participants will get six shots
over four sessions.
vaccine will be an approach to immunizing against AIDS, with the
hopes it will attack the various virus strains around the world.
Scientists from around the world have been aggravated by the lack of
progress in treating and/or curing the virus.
it was Harvard Medical School Professor Dan Barouch’s research that
was key in the development of the J&J vaccine. He said the
approach brings the world even closer to curing the different
strains. He said it’s great, for both the medical and world public
health, to have a vaccine that can work in many areas of the world.
vaccine attempts were focused on a single strain.
for 15 years, has worked tirelessly on ways to address the virus’
multiple strains. With the assistance of computational biologist
Bette Korber, they came up with a set of mosaic proteins that could
increase the immune defense against the strains.
in May, the company said it enrolled 2,600 women between the ages of
18 and 35 in five southern African countries where there is a high
rate of HIV infection among the group, for a similar vaccine
is just one method known to help with the decrease in HIV infection
spread, and that’s PrEP or pre-exposure prophylaxis medication,
which could possibly end the spread of HIV/AIDS. However, it’s a
need-to-take daily medication. Due to the high cost – what many
see as corporate greed on the drugmakers’ part, this is slow to
J&J Chief Scientific Officer Paul Stoffels said the cost of treating these patients is a burden on society and the patients are high, and preventing HIV is a huge job to undertake – something the company has been working on for close to 30 years.